Common ICD-10 Diagnosis Codes for TTE and Stress Echo - September 2015
|
|
|
- Alexia McLaughlin
- 10 years ago
- Views:
Transcription
1 The information provided here is for reference use only. It is based on a compilation of various payer and Medicare coverage policies that were revised to reflect ICD-10 codes. It is not an allinclusive list. This list does not differentiate approved indications by specific payers or represent a guarantee of coverage. Check with your payers for specific guidance and codes. It is the responsibility of the provider to code to the highest level specified in the ICD-10-CM. Refer to the ICD-10-CM manual and guidelines to fully understand the rules and instructions needed to code properly. Certain Infectious and Parasitic Diseases (A00-B99) A18.84 Tuberculosis of heart A22.7 Anthrax sepsis A36.81 Diphtheritic cardiomyopathy A39.53 Meningococcal pericarditis A40.0 Sepsis due to streptococcus, group A A40.1 Sepsis due to streptococcus, group B A40.3 Sepsis due to Streptococcus pneumoniae A40.8 Other streptococcal sepsis A40.9 Streptococcal sepsis, unspecified A41.01 Sepsis due to Methicillin susceptible Staphylococcus aureus A41.02 Sepsis due to Methicillin resistant Staphylococcus aureus A41.1 Sepsis due to other specified staphylococcus A41.2 Sepsis due to unspecified staphylococcus A41.3 Sepsis due to Hemophilus influenzae A41.4 Sepsis due to anaerobes A41.50 Gram-negative sepsis, unspecified A41.51 Sepsis due to Escherichia coli [E. coli] A41.52 Sepsis due to Pseudomonas A41.53 Sepsis due to Serratia A41.59 Other Gram-negative sepsis A41.81 Sepsis due to Enterococcus A41.89 Other specified sepsis A41.9 Sepsis, unspecified organism A42.7 Actinomycotic sepsis A52.01 Syphilitic aneurysm of aorta A52.02 Syphilitic aortitis A52.03 Syphilitic endocarditis A52.06 Other syphilitic heart involvement A54.83 Gonococcal heart infection 1
2 A69.20 Lyme disease, unspecified A69.21 Meningitis due to Lyme disease A69.22 Other neurologic disorders in Lyme disease Certain Infectious and Parasitic Diseases (A00-B99) A69.23 Arthritis due to Lyme disease A69.29 Other conditions associated with Lyme disease B33.21 Viral endocarditis B33.22 Viral myocarditis B33.23 Viral pericarditis B37.6 Candidal endocarditis B39.4 Histoplasmosis capsulati, unspecified B39.5 Histoplasmosis duboisii B57.0 Acute Chagas' disease with heart involvement B57.2 Chagas' disease (chronic) with heart involvement B58.81 Toxoplasma myocarditis Neoplasms (C00-D49) C38.0 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium C79.89 Secondary malignant neoplasm of other specified sites C79.9 Secondary malignant neoplasm of unspecified site D15.1 Benign neoplasm of heart D48.7 Neoplasm of uncertain behavior of other specified sites D48.9 Neoplasm of uncertain behavior, unspecified D49.81 Neoplasm of unspecified behavior of retina and choroid D49.89 Neoplasm of unspecified behavior of other specified sites Disease of the blood/blood-forming organs, certain disorders involving the immune mechanism (D50-D89) D82.1 Di George's syndrome D86.0 Sarcoidosis of lung D86.1 Sarcoidosis of lymph nodes D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes D86.3 Sarcoidosis of skin D86.81 Sarcoid meningitis D86.82 Multiple cranial nerve palsies in sarcoidosis D86.83 Sarcoid iridocyclitis D86.84 Sarcoid pyelonephritis D86.85 Sarcoid myocarditis D86.86 Sarcoid arthropathy D86.87 Sarcoid myositis D86.89 Sarcoidosis of other sites D86.9 Sarcoidosis, unspecified 2
3 Endocrine, Nutritional, and Metabolic Diseases (E00-E89) E03.5 Myxedema coma E Hereditary hemochromatosis E Hemochromatosis due to repeated red blood cell transfusions E Other hemochromatosis E Hemochromatosis, unspecified E83.19 Other disorders of iron metabolism E85.0 Non-neuropathic heredofamilial amyloidosis E85.1 Neuropathic heredofamilial amyloidosis E85.2 Heredofamilial amyloidosis, unspecified E85.3 Secondary systemic amyloidosis E85.4 Organ-limited amyloidosis E85.8 Other amyloidosis E85.9 Amyloidosis, unspecified E86.0 Dehydration E86.1 Hypovolemia E86.9 Volume depletion, unspecified Diseases of the Nervous System (G00-G99) G06.0 Intracranial abscess and granuloma G06.1 Intraspinal abscess and granuloma G45.0 Vertebro-basilar artery syndrome G45.1 Carotid artery syndrome (hemispheric) G45.2 Multiple and bilateral precerebral artery syndromes G45.8 Other transient cerebral ischemic attacks and related syndromes G45.9 Transient cerebral ischemic attack, unspecified G46.0 Middle cerebral artery syndrome G46.1 Anterior cerebral artery syndrome G46.2 Posterior cerebral artery syndrome G47.30 Sleep apnea, unspecified G47.31 Obstructive sleep apnea (adult) (pediatric G47.32 High altitude periodic breathing G47.33 Obstructive sleep apnea (adult) (pediatric) Diseases of the eye and adnexa (H00-H59) H34.01 Transient retinal artery occlusion, right eye H34.02 Transient retinal artery occlusion, left eye H34.03 Transient retinal artery occlusion, bilateral Diseases of the Circulatory System (I00-I99) I01.0 Acute rheumatic endocarditis I01.1 Acute rheumatic endocarditis I01.2 Acute rheumatic myocarditis 3
4 I01.8 Other acute rheumatic heart disease Diseases of the Circulatory System (I00-I99) I01.9 Acute rheumatic heart disease, unspecified I02.0 Rheumatic chorea with heart involvement I02.9 Rheumatic chorea without heart involvement I05.0 Rheumatic mitral stenosis I05.1 Rheumatic mitral insufficiency I05.2 Rheumatic mitral stenosis with insufficiency I05.8 Other rheumatic mitral valve diseases I06.0 Rheumatic aortic stenosis I06.1 Rheumatic aortic insufficiency I06.2 Rheumatic aortic stenosis with insufficiency I06.8 Other rheumatic aortic valve diseases I06.9 Rheumatic aortic valve disease, unspecified I07.0 Rheumatic tricuspid stenosis I07.1 Rheumatic tricuspid insufficiency I07.2 Rheumatic tricuspid stenosis and insufficiency I07.8 Other rheumatic tricuspid valve diseases I08.0 Rheumatic disorders of both mitral and aortic valves I08.1 Rheumatic disorders of both mitral and tricuspid valves I08.2 Rheumatic disorders of both aortic and tricuspid valves I08.3 Combined rheumatic disorders of mitral, aortic and tricuspid valves I08.8 Other rheumatic multiple valve diseases I08.9 Other rheumatic multiple valve diseases I09.0 Rheumatic myocarditis I09.1 Rheumatic diseases of endocardium, valve unspecified I09.2 Chronic rheumatic pericarditis I09.81 Rheumatic heart failure I09.89 Other specified rheumatic heart diseases I09.9 Rheumatic heart disease, unspecified I10 Essential (primary) hypertension I11.0 Hypertensive heart disease with heart failure I11.9 Hypertensive heart disease without heart failure Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage I chronic kidney disease, or unspecified chronic kidney disease Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through I13.10 stage 4 chronic kidney disease, or unspecified chronic kidney disease Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic I13.11 kidney disease, or end stage renal disease Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic I13.2 kidney disease, or end stage renal disease I15.0 Renovascular hypertension I15.8 Other secondary hypertension 4
5 I20.0 Unstable angina I20.1 Angina pectoris with documented spasm I20.8 Other forms of angina pectoris I20.9 Angina pectoris, unspecified I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery I21.02 ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.09 ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall I21.11 ST elevation (STEMI) myocardial infarction involving right coronary artery I21.19 ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall I21.21 ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery I21.29 ST elevation (STEMI) myocardial infarction involving other sites I21.4 Non-ST elevation (NSTEMI) myocardial infarction I22.0 Subsequent ST elevation (STEMI) myocardial infarction of anterior wall I22.1 Subsequent ST elevation (STEMI) myocardial infarction of inferior wall I22.2 Subsequent non-st elevation (NSTEMI) myocardial infarction I22.8 Subsequent ST elevation (STEMI) myocardial infarction of other sites I23.0 Hemopericardium as current complication following acute myocardial infarction I23.1 Atrial septal defect as current complication following acute myocardial infarction I23.2 Ventricular septal defect as current complication following acute myocardial infarction I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction I23.6 Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction I23.7 Postinfarction angina I23.8 Other current complications following acute myocardial infarction I24.0 Acute coronary thrombosis not resulting in myocardial infarction I24.1 Dressler's syndrome I24.8 Other forms of acute ischemic heart disease I24.9 Acute ischemic heart disease, unspecified I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris Old myocardial infarction I25.3 Aneurysm of heart I25.41 Coronary artery aneurysm I25.42 Coronary artery dissection I25.5 Ischemic cardiomyopathy I25.6 Silent myocardial ischemia I Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris 5
6 Diseases of the Circulatory System (I00-I99) I Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of native coronary artery of transplanted heart with unstable angina I Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm I Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris I Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina I Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm I Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris I Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of coronary artery bypass graft(s) without angina pectoris I Atherosclerosis of native coronary artery of transplanted heart without angina pectoris I Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris I25.82 Chronic total occlusion of coronary artery I25.84 Coronary atherosclerosis due to calcified coronary lesion I25.89 Other forms of chronic ischemic heart disease I25.9 Chronic ischemic heart disease, unspecified I26.01 Septic pulmonary embolism with acute cor pulmonale I26.02 Septic pulmonary embolism with acute cor pulmonale I26.09 Other pulmonary embolism with acute cor pulmonale I26.90 Septic pulmonary embolism without acute cor pulmonale I26.92 Saddle embolus of pulmonary artery without acute cor pulmonale I26.99 Other pulmonary embolism without acute cor pulmonale I27.0 Primary pulmonary hypertension I27.2 Other secondary pulmonary hypertension I27.81 Cor pulmonale (chronic) 6
7 Diseases of the Circulatory System (I00-I99) I27.82 Chronic pulmonary embolism I27.89 Other specified pulmonary heart diseases I27.9 Pulmonary heart disease, unspecified I28.0 Arteriovenous fistula of pulmonary vessels I28.1 Aneurysm of pulmonary artery I30.0 Acute nonspecific idiopathic pericarditis I30.1 Infective pericarditis I30.8 Other forms of acute pericarditis I31.0 Chronic adhesive pericarditis I31.1 Chronic constrictive pericarditis I31.2 Hemopericardium, not elsewhere classified I31.3 Pericardial effusion (noninflammatory) I31.4 Cardiac tamponade I31.8 Other specified diseases of pericardium I31.9 Disease of pericardium, unspecified I32 Pericarditis in diseases classified elsewhere I33.0 Acute and subacute infective endocarditis I33.9 Acute and subacute endocarditis, unspecified I34.0 Nonrheumatic mitral (valve) insufficiency I34.1 Nonrheumatic mitral (valve) prolapse I34.2 Nonrheumatic mitral (valve) stenosis I34.8 Other nonrheumatic mitral valve disorders I34.9 Nonrheumatic mitral valve disorder, unspecified I35.0 Nonrheumatic aortic (valve) stenosis I35.1 Nonrheumatic aortic (valve) insufficiency I35.2 Nonrheumatic aortic (valve) stenosis with insufficiency I35.8 Other nonrheumatic aortic valve disorders I35.9 Nonrheumatic aortic valve disorder, unspecified I36.0 Nonrheumatic tricuspid (valve) stenosis I36.1 Nonrheumatic tricuspid (valve) insufficiency Nonrheumatic tricuspid (valve) stenosis with insufficiency I36.8 Other nonrheumatic tricuspid valve disorders I36.9 Nonrheumatic tricuspid valve disorder, unspecified I37.0 Nonrheumatic pulmonary valve stenosis I37.1 Nonrheumatic pulmonary valve insufficiency I37.2 Nonrheumatic pulmonary valve stenosis with insufficiency I37.8 Other nonrheumatic pulmonary valve disorders I37.9 Nonrheumatic pulmonary valve disorder, unspecified I38 Endocarditis, valve unspecified I39 Endocarditis and heart valve disorders in diseases classified elsewhere 7
8 Diseases of the Circulatory System (I00-I99) I40.0 Infective myocarditis I40.1 Isolated myocarditis I40.8 Other acute myocarditis I40.9 Acute myocarditis, unspecified I41 Myocarditis in diseases classified elsewhere I42.0 Dilated cardiomyopathy I42.1 Obstructive hypertrophic cardiomyopathy I42.2 Other hypertrophic cardiomyopathy I42.3 Endomyocardial (eosinophilic) disease I42.4 Endocardial fibroelastosis I42.5 Other restrictive cardiomyopathy I42.6 Alcoholic cardiomyopathy I42.7 Cardiomyopathy due to drug and external agent I42.8 Other cardiomyopathies I42.9 Cardiomyopathy, unspecified I43 Cardiomyopathy in diseases classified elsewhere I43 Cardiomyopathy in diseases classified elsewhere I44.1 Atrioventricular block, second degree I44.2 Atrioventricular block, complete I44.30 Unspecified atrioventricular block I44.39 Other atrioventricular block I44.7 Left bundle-branch block, unspecified I45.2 Bifascicular block I45.3 Trifascicular block I45.4 Nonspecific intraventricular block I45.5 Other specified heart block I45.6 Pre-excitation syndrome I45.9 Conduction disorder, unspecified I46.2 Cardiac arrest due to underlying cardiac condition I46.8 Cardiac arrest due to other underlying condition I46.9 Cardiac arrest, cause unspecified I47.0 Re-entry ventricular arrhythmia I47.1 Supraventricular tachycardia I47.2 Ventricular tachycardia I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter I48.4 Atypical atrial flutter I48.91 Unspecified atrial fibrillation 8
9 Diseases of the Circulatory System (I00-I99) I48.92 Unspecified atrial flutter I49.01 Ventricular fibrillation I49.02 Ventricular flutter I49.1 Atrial premature depolarization I49.2 Junctional premature depolarization I49.3 Ventricular premature depolarization I49.40 Unspecified premature depolarization I49.49 Other premature depolarization I49.5 Sick sinus syndrome I49.8 Other specified cardiac arrhythmias I49.9 Cardiac arrhythmia, unspecified I50.1 Left ventricular failure I50.20 Unspecified systolic (congestive) heart failure I50.21 Acute systolic (congestive) heart failure I50.22 Chronic systolic (congestive) heart failure I50.23 Acute on chronic systolic (congestive) heart failure I50.30 Unspecified diastolic (congestive) heart failure I50.31 Acute diastolic (congestive) heart failure I50.32 Chronic diastolic (congestive) heart failure I50.33 Acute on chronic diastolic (congestive) heart failure I50.40 Unspecified combined systolic (congestive) and diastolic (congestive) heart failure I50.41 Acute combined systolic (congestive) and diastolic (congestive) heart failure I50.42 Chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.43 Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.9 Heart failure, unspecified I51.0 Cardiac septal defect, acquired I51.1 Rupture of chordae tendineae, not elsewhere classified I51.2 Rupture of papillary muscle, not elsewhere classified I51.4 Myocarditis, unspecified I51.7 Cardiomegaly I51.81 Takotsubo syndrome I51.89 Other ill-defined heart diseases I51.9 Heart disease, unspecified I60.01 Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation I60.02 Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation I60.11 Nontraumatic subarachnoid hemorrhage from right middle cerebral artery I60.12 Nontraumatic subarachnoid hemorrhage from left middle cerebral artery I60.21 Nontraumatic subarachnoid hemorrhage from right anterior communicating artery I60.22 Nontraumatic subarachnoid hemorrhage from left anterior communicating artery I60.31 Nontraumatic subarachnoid hemorrhage from right posterior communicating artery 9
10 Diseases of the Circulatory System (I00-I99) I60.32 Nontraumatic subarachnoid hemorrhage from left posterior communicating artery I60.4 Nontraumatic subarachnoid hemorrhage from basilar artery I60.51 Nontraumatic subarachnoid hemorrhage from right vertebral artery I60.52 Nontraumatic subarachnoid hemorrhage from left vertebral artery I60.6 Nontraumatic subarachnoid hemorrhage from other intracranial arteries I60.7 Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery I60.8 Other nontraumatic subarachnoid hemorrhage I Cerebral infarction due to thrombosis of right middle cerebral artery I Cerebral infarction due to thrombosis of left middle cerebral artery I Cerebral infarction due to thrombosis of right anterior cerebral artery I Cerebral infarction due to thrombosis of left anterior cerebral artery I Cerebral infarction due to thrombosis of right posterior cerebral artery I Cerebral infarction due to thrombosis of left posterior cerebral artery I Cerebral infarction due to thrombosis of right cerebellar artery I Cerebral infarction due to thrombosis of left cerebellar artery I63.39 Cerebral infarction due to thrombosis of other cerebral artery I Cerebral infarction due to embolism of right middle cerebral artery I Cerebral infarction due to embolism of left middle cerebral artery I Cerebral infarction due to embolism of right anterior cerebral artery I Cerebral infarction due to embolism of left anterior cerebral artery I Cerebral infarction due to embolism of right posterior cerebral artery I Cerebral infarction due to embolism of left posterior cerebral artery I Cerebral infarction due to embolism of right cerebellar artery I Cerebral infarction due to embolism of left cerebellar artery I63.49 Cerebral infarction due to embolism of other cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery I Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery I63.59 Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic I63.8 Other cerebral infarction I66.01 Occlusion and stenosis of right middle cerebral artery I66.02 Occlusion and stenosis of left middle cerebral artery I66.03 Occlusion and stenosis of bilateral middle cerebral arteries I66.09 Occlusion and stenosis of unspecified middle cerebral artery 10
11 Diseases of the Circulatory System (I00-I99) I66.11 Occlusion and stenosis of right anterior cerebral artery I66.12 Occlusion and stenosis of left anterior cerebral artery I66.13 Occlusion and stenosis of bilateral anterior cerebral arteries I66.19 Occlusion and stenosis of unspecified anterior cerebral artery I66.21 Occlusion and stenosis of right posterior cerebral artery I66.22 Occlusion and stenosis of left posterior cerebral artery I66.23 Occlusion and stenosis of bilateral posterior cerebral arteries I66.29 Occlusion and stenosis of unspecified posterior cerebral artery I66.3 Occlusion and stenosis of cerebellar arteries I66.8 Occlusion and stenosis of other cerebral arteries I Reversible cerebrovascular vasoconstriction syndrome I Other cerebrovascular vasospasm and vasoconstriction I67.89 Other cerebrovascular disease I70.0 Atherosclerosis of aorta I71.01 Dissection of thoracic aorta I71.03 Dissection of thoracoabdominal aorta I71.1 Thoracic aortic aneurysm, ruptured I71.2 Thoracic aortic aneurysm, without rupture I Unspecified atherosclerosis of native arteries of extremities, right leg I Unspecified atherosclerosis of native arteries of extremities, left leg I Unspecified atherosclerosis of native arteries of extremities, bilateral legs I Unspecified atherosclerosis of native arteries of extremities, other extremity I Unspecified atherosclerosis of native arteries of extremities, unspecified extremity I70.92 Chronic total occlusion of artery of the extremities I71.00 Dissection of unspecified site of aorta I71.01 Dissection of thoracic aorta I71.03 Dissection of thoracoabdominal aorta I71.1 Thoracic aortic aneurysm, ruptured I71.2 Thoracic aortic aneurysm, without rupture I71.5 Thoracoabdominal aortic aneurysm, ruptured I71.6 Thoracoabdominal aortic aneurysm, without rupture I71.8 Aortic aneurysm of unspecified site, ruptured I74.01 Saddle embolus of abdominal aorta I74.09 Other arterial embolism and thrombosis of abdominal aorta I74.10 Embolism and thrombosis of unspecified parts of aorta I74.11 Embolism and thrombosis of thoracic aorta I74.19 Embolism and thrombosis of other parts of aorta I74.2 Embolism and thrombosis of arteries of the upper extremities I74.3 Embolism and thrombosis of arteries of the lower extremities I74.5 Embolism and thrombosis of iliac artery 11
12 Diseases of the Circulatory System (I00-I99) I74.8 Embolism and thrombosis of other arteries I74.9 Embolism and thrombosis of unspecified artery I76 Septic arterial embolism I79.0 Aneurysm of aorta in diseases classified elsewhere I95.1 Orthostatic hypotension I95.2 Hypotension due to drugs I95.81 Postprocedural hypotension I95.89 Other hypotension I95.9 Hypotension, unspecified I97.0 Postcardiotomy syndrome I Postprocedural cardiac insufficiency following cardiac surgery I Postprocedural cardiac insufficiency following other surger I Postprocedural cardiac arrest following cardiac surgery I Postprocedural cardiac arrest following other surgery I Postprocedural heart failure following cardiac surgery I Postprocedural heart failure following other surgery I Other postprocedural cardiac functional disturbances following cardiac surgery I Other postprocedural cardiac functional disturbances following other surgery I Intraoperative cardiac arrest during cardiac surgery I Intraoperative cardiac arrest during other surgery I Other intraoperative cardiac functional disturbances during cardiac surgery I Other intraoperative cardiac functional disturbances during other surgery I97.88 Other intraoperative complications of the circulatory system, not elsewhere classified I97.89 Other postprocedural complications and disorders of the circulatory system, not elsewhere classified Diseases of the Respiratory System (J00-J99) J80 Acute respiratory distress syndrome J81.0 Acute pulmonary edema J95.1 Acute pulmonary insufficiency following thoracic surgery J95.2 Acute pulmonary insufficiency following nonthoracic surgery J95.3 Chronic pulmonary insufficiency following surgery J Acute postprocedural respiratory failure J Acute and chronic postprocedural respiratory failure J95.84 Transfusion-related acute lung injury (TRALI) J96.00 Acute respiratory failure, unspecified whether with hypoxia or hypercapnia J96.01 Acute respiratory failure with hypoxia J96.02 Acute respiratory failure with hypercapnia J96.20 Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia J96.21 Acute and chronic respiratory failure with hypoxia J96.22 Acute and chronic respiratory failure with hypercapnia 12
13 Diseases of the Digestive System (K00-K95) K68.11 Postprocedural retroperitoneal abscess Diseases of the Musculoskeletal System and Connective Tissue (M00-M99) M30.3 Mucocutaneous lymph node syndrome [Kawasaki] M31.4 Aortic arch syndrome [Takayasu] M32.0 Drug-induced systemic lupus erythematosus M32.10 Systemic lupus erythematosus, organ or system involvement unspecified M32.11 Endocarditis in systemic lupus erythematosus M32.19 Other organ or system involvement in systemic lupus erythematosus Diseases of the Musculoskeletal System and Connective Tissue (M00-M99) M32.8 Other forms of systemic lupus erythematosus M32.9 Systemic lupus erythematosus, unspecified Diseases of Genitourinary System (N00-N99) N26.2 Page kidney N98.0 Infection associated with artificial insemination Pregnancy, Childbirth, and the Puerperium (O00-O9A) O35.8XX1- O35.8XX9 Maternal care for other (suspected) fetal abnormality and damage O35.9XX1- O35.9XX9 Maternal care for (suspected) fetal abnormality and damage, unspecified O90.3 Peripartum cardiomyopathy Certain Conditions Originating in the Perinatal Period (P00-P96) P00.89 Newborn (suspected to be) affected by other maternal conditions P22.8 Other respiratory distress of newborn P22.9 Respiratory distress of newborn, unspecified P28.3 Primary sleep apnea of newborn P28.4 Other apnea of newborn P28.89 Other specified respiratory conditions of newborn P29.0 Neonatal cardiac failure P29.11 Neonatal tachycardia P29.12 Neonatal bradycardia P P29.4 Neonatal hypertension - Transient myocardial ischemia in newborn P29.89 Other cardiovascular disorders originating in the perinatal period P94.1 Congenital hypertonia P94.2 Congenital hypotonia P94.8 Other disorders of muscle tone of newborn P96.0 Congenital renal failure P96.3 Wide cranial sutures of newborn P96.5 Complication to newborn due to (fetal) intrauterine procedure Congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) Q20.0 Common arterial trunk Q20.1 Double outlet right ventricle 13
14 Congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) Q20.2 Double outlet left ventricle Q20.3 Discordant ventriculoarterial connection Q20.3 Discordant ventriculoarterial connection Q20.4 Double inlet ventricle Q20.5 Discordant atrioventricular connection Q20.6 Isomerism of atrial appendages Q20.8 Other congenital malformations of cardiac chambers and connections Q20.9 Congenital malformation of cardiac chambers and connections, unspecified Q21.0 Ventricular septal defect Q21.1 Atrial septal defect Q21.2 Atrioventricular septal defect Q21.3 Tetralogy of Fallot Q21.4 Aortopulmonary septal defect Q21.8 Other congenital malformations of cardiac septa Q21.9 Congenital malformation of cardiac septum, unspecified Q22.0 Pulmonary valve atresia Q22.1 Congenital pulmonary valve stenosis Q22.2 Congenital pulmonary valve insufficiency Q22.3 Other congenital malformations of pulmonary valve Q22.4 Congenital tricuspid stenosis Q22.5 Ebstein's anomaly Q22.6 Hypoplastic right heart syndrome Q22.8 Other congenital malformations of tricuspid valve Q22.9 Congenital malformation of tricuspid valve, unspecified Q23.0 Congenital stenosis of aortic valve Q23.1 Congenital insufficiency of aortic valve Q23.2 Congenital mitral stenosis Q23.3 Congenital mitral insufficiency Q23.4 Hypoplastic left heart syndrome Q23.8 Other congenital malformations of aortic and mitral valves Q23.9 Congenital malformation of aortic and mitral valves, unspecified Q24.0 Dextrocardia Q24.1 Levocardia Q24.2 Cor triatriatum Q24.3 Pulmonary infundibular stenosis Q24.4 Congenital subaortic stenosis Q24.5 Malformation of coronary vessels Q24.6 Congenital heart block Q24.8 Other specified congenital malformations of heart Q24.9 Congenital malformation of heart, unspecified 14
15 Congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) Q25.0 Patent ductus arteriosus Q25.1 Coarctation of aorta Q25.2 Atresia of aorta Q25.3 Supravalvular aortic stenosis Q25.4 Other congenital malformations of aorta Q25.5 Atresia of pulmonary artery Q25.6 Stenosis of pulmonary artery Q25.8 Other congenital malformations of other great arteries Q25.5 Atresia of pulmonary artery Q25.71 Coarctation of pulmonary artery Q25.72 Congenital pulmonary arteriovenous malformation Q25.79 Other congenital malformations of pulmonary artery Q25.6 Stenosis of pulmonary artery Q25.79 Other congenital malformations of pulmonary artery Q25.8 Other congenital malformations of other great arteries Q25.9 Congenital malformation of great arteries, unspecified Q26.0 Congenital stenosis of vena cava Q26.1 Persistent left superior vena cava Q26.2 Total anomalous pulmonary venous connection Q26.3 Partial anomalous pulmonary venous connection Q26.4 Anomalous pulmonary venous connection, unspecified Q26.8 Other congenital malformations of great veins Q26.9 Congenital malformation of great vein, unspecified Q27.0 Congenital absence and hypoplasia of umbilical artery Q27.9 Congenital malformation of peripheral vascular system, unspecified Q28.2 Arteriovenous malformation of cerebral vessels Q28.3 Other malformations of cerebral vessels Q28.9 Congenital malformation of circulatory system, unspecified Q30.0 Choanal atresia Q33.2 Sequestration of lung Q33.3 Agenesis of lung Q33.6 Congenital hypoplasia and dysplasia of lung Q40.1 Congenital hiatus hernia Q67.6 Pectus excavatum Q67.7 Pectus carinatum Q87.40 Marfan's syndrome, unspecified Q Marfan's syndrome with aortic dilation Q Marfan's syndrome with other cardiovascular manifestations Q87.42 Marfan's syndrome with ocular manifestations Q87.43 Marfan's syndrome with skeletal manifestation 15
16 Congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) Q89.01 Asplenia (congenital) Q89.09 Congenital malformations of spleen Q89.3 Situs inversus Q89.7 Multiple congenital malformations, not elsewhere classified Q89.9 Congenital malformation, unspecified Q90.0 Trisomy 21, nonmosaicism (meiotic nondisjunction) Q90.1 Trisomy 21, mosaicism (mitotic nondisjunction) Q90.2 Trisomy 21, translocation Q Q91.6 Trisomy 18, nonmosaicism (meiotic nondisjunction) - Trisomy 13, translocation Q96.0 Karyotype 45, X Q96.1 Karyotype 46, X iso (Xq) Q96.2 Karyotype 46, X with abnormal sex chromosome, except iso (Xq) Q96.3 Mosaicism, 45, X/46, XX or XY Q96.4 Mosaicism, 45, X/other cell line(s) with abnormal sex chromosome Q96.8 Other variants of Turner's syndrome Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) R00.1 Bradycardia, unspecified R00.2 Palpitations R00.8 Other abnormalities of heart beat R00.9 Unspecified abnormalities of heart beat R01.0 Benign and innocent cardiac murmurs R01.1 Cardiac murmur, unspecified R01.2 Other cardiac sounds R06.00 Dyspnea, unspecified R06.02 Shortness of breath R06.09 Other forms of dyspnea R06.3 Periodic breathing R06.83 Snoring R06.89 Other abnormalities of breathing R07.2 Precordial pain R07.82 Intercostal pain R07.89 Other chest pain R07.9 Chest pain, unspecified R09.2 Respiratory arrest R22.2 Localized swelling, mass and lump, trunk R23.0 Cyanosis R Coma scale, eyes open, never, unspecified time R Coma scale, eyes open, never, in the field [EMT or ambulance] R Coma scale, eyes open, never, at arrival to emergency department R Coma scale, eyes open, never, at hospital admission 16
17 Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99) R Coma scale, eyes open, never, 24 hours or more after hospital admission R Coma scale, eyes open, to pain, unspecified time R Coma scale, eyes open, to pain, in the field [EMT or ambulance] R Coma scale, eyes open, to pain, at arrival to emergency department R Coma scale, eyes open, to pain, at hospital admission R Coma scale, eyes open, to pain, 24 hours or more after hospital admission R Coma scale, best verbal response, none, unspecified time R Coma scale, best verbal response, none, in the field [EMT or ambulance] R Coma scale, best verbal response, none, at arrival to emergency department R Coma scale, best verbal response, none, at hospital admission R Coma scale, best verbal response, none, 24 hours or more after hospital admission Coma scale, best verbal response, incomprehensible words, in the field [EMT or R ambulance] - Coma scale, best verbal response, incomprehensible words, 24 hours or more R after hospital admission R Coma scale, best motor response, none, in the field [EMT or ambulance] - Coma scale, R R R R R best motor response, none, 24 hours or more after hospital admission Coma scale, best motor response, extension, in the field [EMT or ambulance] - Coma scale, best motor response, extension, 24 hours or more after hospital admission Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance] - Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission R40.4 Transient alteration of awareness R47.01 Aphasia R50.2 Drug induced fever R50.81 Fever presenting with conditions classified elsewhere R50.9 Fever, unspecified R55 Syncope and collapse R57.0 Cardiogenic shock R57.1 Hypovolemic shock R57.8 Other shock R57.9 Shock, unspecified R60.0 Localized edema R60.1 Localized edema R65.20 Severe sepsis without septic shock R65.21 Severe sepsis with septic shock R78.81 Bacteremia R94.30 Abnormal result of cardiovascular function study, unspecified R94.31 Abnormal electrocardiogram [ECG] [EKG] Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) Unspecified open wound of unspecified front wall of thorax with penetration into thoracic S21.309A cavity, initial S22.5XXA S22.5XXB Flail chest, initial for closed fracture Flail chest, initial for open fracture 17
18 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) S25.00XA Unspecified injury of thoracic aorta, initial S25.01XA Minor laceration of thoracic aorta, initial S25.02XA Major laceration of thoracic aorta, initial S25.09XA Other specified injury of thoracic aorta, initial S25.22XA Major laceration of superior vena cava, initial S25.29XA Other specified injury of superior vena cava, initial S25.401A Unspecified injury of right pulmonary blood vessels, initial S25.402A Unspecified injury of left pulmonary blood vessels, initial S25.411A Minor laceration of right pulmonary blood vessels, initial S25.412A Minor laceration of left pulmonary blood vessels, initial S25.421A Major laceration of right pulmonary blood vessels, initial S25.422A Major laceration of left pulmonary blood vessels, initial S25.491A Other specified injury of right pulmonary blood vessels, initial S25.492A Other specified injury of left pulmonary blood vessels, initial S25.499A Other specified injury of unspecified pulmonary blood vessels, initial S25.91XA Laceration of unspecified blood vessel of thorax, initial S25.99XA Other specified injury of unspecified blood vessel of thorax, initial S26.01XA Contusion of heart with hemopericardium, initial S26.020A Mild laceration of heart with hemopericardium, initial S26.021A Moderate laceration of heart with hemopericardium, initial S26.022A Major laceration of heart with hemopericardium, initial S26.09XA Other injury of heart with hemopericardium, initial S26.11XA Contusion of heart without hemopericardium, initial S26.12XA Laceration of heart without hemopericardium, initial S26.19XA Other injury of heart without hemopericardium, initial S26.91XA Contusion of heart, unspecified with or without hemopericardium, initial encou S26.92XA Laceration of heart, unspecified with or without hemopericardium, initial S26.99XA Other injury of heart, unspecified with or without hemopericardium, initial T36.0X5A Adverse effect of penicillins, initial T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial T36.2X5A Adverse effect of chloramphenicol group, initial T36.3X5A Adverse effect of macrolides, initial T36.4X5A Adverse effect of tetracyclines, initial T36.5X5A Adverse effect of aminoglycosides, initial T36.6X5A Adverse effect of rifampicins, initial T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial T36.8X5A Adverse effect of other systemic antibiotics, initial T37.0X5A Adverse effect of sulfonamides, initial T37.1X5A Adverse effect of antimycobacterial drugs, initial T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial 18
19 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T37.3X5A T37.4X5A T37.5X5A T37.8X5A T38.0X1A Adverse effect of other antiprotozoal drugs, initial Adverse effect of anthelminthics, initial Adverse effect of antiviral drugs, initial Adverse effect of other specified systemic anti-infectives and antiparasitics, initial Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial T38.0X2A T38.0X3A T38.0X5A T38.1X5A T38.2X5A T38.4X5A T38.5X5A T38.6X5A T38.7X5A T38.815A T38.895A T38.995A T39.015A T39.095A T39.1X5A T39.2X5A T39.315A T39.395A T39.4X5A T39.8X5A T40.0X5A T40.2X1A T40.2X3A T40.2X4A T40.2X5A T40.3X5A T40.4X1A T40.4X2A T40.4X3A T40.4X5A T40.5X5A T40.691A Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial Poisoning by glucocorticoids and synthetic analogues, assault, initial Adverse effect of glucocorticoids and synthetic analogues, initial Adverse effect of thyroid hormones and substitutes, initial Adverse effect of antithyroid drugs, initial Adverse effect of oral contraceptives, initial Adverse effect of other estrogens and progestogens, initial Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial Adverse effect of androgens and anabolic congeners, initial Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial Adverse effect of other hormones and synthetic substitutes, initial Adverse effect of other hormone antagonists, initial Adverse effect of aspirin, initial Adverse effect of salicylates, initial Adverse effect of 4-Aminophenol derivatives, initial Adverse effect of pyrazolone derivatives, initial Adverse effect of propionic acid derivatives, initial Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial Adverse effect of antirheumatics, not elsewhere classified, initial Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial Adverse effect of opium, initial Poisoning by other opioids, accidental (unintentional), initial Poisoning by other opioids, assault, initial Poisoning by other opioids, undetermined, initial Adverse effect of other opioids, initial Adverse effect of methadone, initial Poisoning by other synthetic narcotics, accidental (unintentional), initial Poisoning by other synthetic narcotics, intentional self-harm, initial Poisoning by other synthetic narcotics, assault, initial Adverse effect of other synthetic narcotics, initial Adverse effect of cocaine, initial Poisoning by other narcotics, accidental (unintentional), initial 19
20 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T40.692A T40.693A T40.695A T40.7X5A T40.995A T41.0X5A T41.1X5A T41.295A T41.3X5A T41.5X5A T42.0X5A T42.1X5A T42.2X5A T42.3X5A T42.4X5A T42.5X5A T42.6X5A T42.8X5A T43.015A T43.025A T43.1X5A T43.215A T43.225A T43.295A T43.3X5A T43.4X5A T43.595A T43.615A T43.625A T43.635A T43.695A T43.8X5A T44.0X5A T44.1X5A T44.2X1A T44.2X2A T44.2X3A T44.2X5A T44.3X5A Poisoning by other narcotics, intentional self-harm, initial Poisoning by other narcotics, assault, initial Adverse effect of other narcotics, initial Adverse effect of cannabis (derivatives), initial Adverse effect of other psychodysleptics [hallucinogens], initial Adverse effect of inhaled anesthetics, initial Adverse effect of intravenous anesthetics, initial Adverse effect of other general anesthetics, initial Adverse effect of local anesthetics, initial Adverse effect of therapeutic gases, initial Adverse effect of hydantoin derivatives, initial Adverse effect of iminostilbenes, initial Adverse effect of succinimides and oxazolidinediones, initial Adverse effect of barbiturates, initial Adverse effect of benzodiazepines, initial Adverse effect of mixed antiepileptics, initial Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial Adverse effect of tricyclic antidepressants, initial Adverse effect of tetracyclic antidepressants, initial Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial Adverse effect of selective serotonin reuptake inhibitors, initial Adverse effect of other antidepressants, initial Adverse effect of phenothiazine antipsychotics and neuroleptics, initial Adverse effect of butyrophenone and thiothixene neuroleptics, initial Adverse effect of other antipsychotics and neuroleptics, initial Adverse effect of caffeine, initial Adverse effect of amphetamines, initial Adverse effect of methylphenidate, initial Adverse effect of other psychostimulants, initial Adverse effect of other psychotropic drugs, initial Adverse effect of anticholinesterase agents, initial Adverse effect of other parasympathomimetics [cholinergics], initial Poisoning by ganglionic blocking drugs, accidental (unintentional), initial Poisoning by ganglionic blocking drugs, intentional self-harm, initial Poisoning by ganglionic blocking drugs, assault, initial Adverse effect of ganglionic blocking drugs, initial Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial 20
21 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T44.4X5A T44.5X5A T44.6X5A T44.7X5A T44.8X5A T44.995A T45.0X1A T45.0X2A T45.0X3A T45.0X5A T45.1X1A T45.1X2A T45.1X3A T45.1X5A T45.1X5S T45.2X5A T45.3X5A T45.4X5A T45.515A T45.525A T45.615A T45.625A T45.695A T45.7X5A T45.8X5A T46.0X1A T46.0X2A T46.0X3A T46.0X5A T46.1X1A T46.1X2A T46.1X3A T46.1X5A T46.2X1A T46.2X2A T46.2X3A T46.2X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial Adverse effect of predominantly beta-adrenoreceptor agonists, initial Adverse effect of alpha-adrenoreceptor antagonists, initial Adverse effect of beta-adrenoreceptor antagonists, initial Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial Adverse effect of other drug primarily affecting the autonomic nervous system, initial Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial Poisoning by antiallergic and antiemetic drugs, assault, initial Adverse effect of antiallergic and antiemetic drugs, initial Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial Poisoning by antineoplastic and immunosuppressive drugs, assault, initial Adverse effect of antineoplastic and immunosuppressive drugs, initial Adverse effect of antineoplastic and immunosuppressive drugs, sequela Adverse effect of vitamins, initial Adverse effect of enzymes, initial Adverse effect of iron and its compounds, initial Adverse effect of anticoagulants, initial Adverse effect of antithrombotic drugs, initial Adverse effect of thrombolytic drugs, initial Adverse effect of hemostatic drug, initial Adverse effect of other fibrinolysis-affecting drugs, initial Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial Adverse effect of other primarily systemic and hematological agents, initial Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial Poisoning by calcium-channel blockers, accidental (unintentional), initial Poisoning by calcium-channel blockers, intentional self-harm, initial Poisoning by calcium-channel blockers, assault, initial Adverse effect of calcium-channel blockers, initial Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial Poisoning by other antidysrhythmic drugs, intentional self-harm, initial Poisoning by other antidysrhythmic drugs, assault, initial Adverse effect of other antidysrhythmic drugs, initial 21
22 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial T46.3X2A Poisoning by coronary vasodilators, intentional self-harm, initial T46.3X3A Poisoning by coronary vasodilators, assault, initial T46.3X5A Adverse effect of coronary vasodilators, initial T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial T46.5X3A Poisoning by other antihypertensive drugs, assault, initial T46.5X5A Adverse effect of other antihypertensive drugs, initial T46.6X1A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial T46.6X2A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial T46.6X3A T46.6X5A T46.7X1A T46.7X2A T46.7X3A T46.7X5A T46.8X1A T46.8X2A T46.8X3A T46.8X5A T46.901A T46.902A T46.903A T46.905A T46.991A T46.992A T46.993A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial Poisoning by peripheral vasodilators, accidental (unintentional), initial Poisoning by peripheral vasodilators, intentional self-harm, initial Poisoning by peripheral vasodilators, assault, initial Adverse effect of peripheral vasodilators, initial Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial Poisoning by antivaricose drugs, including sclerosing agents, assault, initial Adverse effect of antivaricose drugs, including sclerosing agents, initial Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional selfharm, initial Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial Poisoning by other agents primarily affecting the cardiovascular system, intentional selfharm, initial Poisoning by other agents primarily affecting the cardiovascular system, assault, initial 22
23 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) Adverse effect of other agents primarily affecting the cardiovascular system, initial T46.995A T47.0X5A T47.1X5A T47.2X5A T47.3X5A T47.4X5A T47.5X5A T47.6X5A T47.7X5A T47.8X5A T48.0X5A T48.1X5A T48.295A T48.3X5A T48.4X5A T48.5X5A T48.6X5A T48.995A T49.0X5A T49.1X5A T49.2X5A T49.3X5A T49.4X5A T49.5X5A T49.6X5A T49.7X5A T49.8X5A T50.0X1A T50.0X2A T50.0X3A T50.0X5A T50.1X5A T50.2X5A T50.3X5A T50.4X5A T50.5X5A T50.6X5A Adverse effect of histamine H2-receptor blockers, initial Adverse effect of other antacids and anti-gastric-secretion drugs, initial Adverse effect of stimulant laxatives, initial Adverse effect of saline and osmotic laxatives, initial Adverse effect of other laxatives, initial Adverse effect of digestants, initial Adverse effect of antidiarrheal drugs, initial Adverse effect of emetics, initial Adverse effect of other agents primarily affecting gastrointestinal system, initial Adverse effect of oxytocic drugs, initial Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial Adverse effect of other drugs acting on muscles, initial Adverse effect of antitussives, initial Adverse effect of expectorants, initial Adverse effect of other anti-common-cold drugs, initial Adverse effect of antiasthmatics, initial Adverse effect of other agents primarily acting on the respiratory system, initial Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial Adverse effect of antipruritics, initial Adverse effect of local astringents and local detergents, initial Adverse effect of emollients, demulcents and protectants, initial Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial Adverse effect of ophthalmological drugs and preparations, initial Adverse effect of otorhinolaryngological drugs and preparations, initial Adverse effect of dental drugs, topically applied, initial Adverse effect of other topical agents, initial Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial Poisoning by mineralocorticoids and their antagonists, assault, initial Adverse effect of mineralocorticoids and their antagonists, initial Adverse effect of loop [high-ceiling] diuretics, initial Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial Adverse effect of electrolytic, caloric and water-balance agents, initial Adverse effect of drugs affecting uric acid metabolism, initial Adverse effect of appetite depressants, initial Adverse effect of antidotes and chelating agents, initial 23
24 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T50.7X5A T50.8X5A T50.A15A T50.A25A T50.A95A T50.B15A T50.B95A T50.Z15A T50.Z95A T50.905A T50.995A T51.3X1A T51.3X2A T51.3X3A T58.01XA T58.02XA T58.03XA T58.11XA T58.12XA T58.13XA T58.2X1A T58.2X2A Adverse effect of analeptics and opioid receptor antagonists, initial Adverse effect of diagnostic agents, initial Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial Adverse effect of mixed bacterial vaccines without a pertussis component, initial Adverse effect of other bacterial vaccines, initial Adverse effect of smallpox vaccines, initial Adverse effect of other viral vaccines, initial Adverse effect of immunoglobulin, initial Adverse effect of other vaccines and biological substances, initial Adverse effect of unspecified drugs, medicaments and biological substances, initial Adverse effect of other drugs, medicaments and biological substances, initial Toxic effect of fusel oil, accidental (unintentional), initial Toxic effect of fusel oil, intentional self-harm, initial Toxic effect of fusel oil, assault, initial Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial Toxic effect of carbon monoxide from motor vehicle exhaust, assault, initial Toxic effect of carbon monoxide from utility gas, accidental (unintentional), initial Toxic effect of carbon monoxide from utility gas, intentional self-harm, initial Toxic effect of carbon monoxide from utility gas, assault, initial Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial T58.2X3A T58.8X1A T58.8X2A T58.8X3A T66.XXXA T75.01XA T75.09XA T75.4XXA T79.0XXA T79.1XXA T79.4XXA T79.4XXA T80.0XXA Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial Toxic effect of carbon monoxide from other source, accidental (unintentional), initial Toxic effect of carbon monoxide from other source, intentional self-harm, initial Toxic effect of carbon monoxide from other source, assault, initial Radiation sickness, unspecified, initial Shock due to being struck by lightning, initial Other effects of lightning, initial Electrocution, initial Air embolism (traumatic), initial Fat embolism (traumatic), initial Traumatic shock, initial Traumatic shock, initial Air embolism following infusion, transfusion and therapeutic injection, initial 24
25 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T80.211A T80.212A T80.218A T80.22XA T80.29XA T80.51XA T80.52XA T80.59XA T81.10XA T81.11XA T81.12XA T81.19XA T81.4XXA T81.718A T81.72XA T82.01XA T82.02XA T82.03XA T82.09XA T82.110A T82.111A T82.118A T82.120A T82.121A T82.128A T82.129A T82.190A T82.191A T82.198A T82.211A T82.212A T82.213A T82.221A T82.222A T82.223A T82.228A T82.310A T82.311A T82.312A Bloodstream infection due to central venous catheter, initial Local infection due to central venous catheter, initial Other infection due to central venous catheter, initial Acute infection following transfusion, infusion, or injection of blood and blood products, initial Infection following other infusion, transfusion and therapeutic injection, initial Anaphylactic reaction due to administration of blood and blood products, initial Anaphylactic reaction due to vaccination, initial Anaphylactic reaction due to other serum, initial Postprocedural shock unspecified, initial Postprocedural cardiogenic shock, initial Postprocedural septic shock, initial Other postprocedural shock, initial Infection following a procedure, initial Complication of other artery following a procedure, not elsewhere classified, initial Complication of vein following a procedure, not elsewhere classified, initial Breakdown (mechanical) of heart valve prosthesis, initial Displacement of heart valve prosthesis, initial Leakage of heart valve prosthesis, initial Other mechanical complication of heart valve prosthesis, initial Breakdown (mechanical) of cardiac electrode, initial Breakdown (mechanical) of cardiac pulse generator (battery), initial Breakdown (mechanical) of other cardiac electronic device, initial Displacement of cardiac electrode, initial Displacement of cardiac pulse generator (battery), initial Displacement of other cardiac electronic device, initial Displacement of unspecified cardiac electronic device, initial Other mechanical complication of cardiac electrode, initial Other mechanical complication of cardiac pulse generator (battery), initial Other mechanical complication of other cardiac electronic device, initial Breakdown (mechanical) of coronary artery bypass graft, initial Displacement of coronary artery bypass graft, initial Leakage of coronary artery bypass graft, initial Breakdown (mechanical) of biological heart valve graft, initial Displacement of biological heart valve graft, initial Leakage of biological heart valve graft, initial Other mechanical complication of biological heart valve graft, initial Breakdown (mechanical) of aortic (bifurcation) graft (replacement), initial Breakdown (mechanical) of carotid arterial graft (bypass), initial Breakdown (mechanical) of femoral arterial graft (bypass), initial 25
26 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T82.318A T82.320A T82.321A T82.322A T82.328A T82.330A T82.331A T82.332A T82.338A T82.390A T82.391A T82.392A T82.398A T82.41XA T82.42XA T82.43XA T82.510A T82.511A T82.512A T82.513A T82.514A T82.515A T82.518A T82.520A T82.521A T82.522A T82.523A T82.524A T82.525A T82.528A T82.530A T82.531A T82.533A T82.534A T82.535A T82.538A T82.590A T82.591A T82.593A T82.594A Breakdown (mechanical) of other vascular grafts, initial Displacement of aortic (bifurcation) graft (replacement), initial Displacement of carotid arterial graft (bypass), initial Displacement of femoral arterial graft (bypass), initial Displacement of other vascular grafts, initial Leakage of aortic (bifurcation) graft (replacement), initial Leakage of carotid arterial graft (bypass), initial Leakage of femoral arterial graft (bypass), initial Leakage of other vascular grafts, initial Other mechanical complication of aortic (bifurcation) graft (replacement), initial Other mechanical complication of carotid arterial graft (bypass), initial encoun Other mechanical complication of femoral arterial graft (bypass), initial Other mechanical complication of other vascular grafts, initial Breakdown (mechanical) of vascular dialysis catheter, initial Displacement of vascular dialysis catheter, initial Leakage of vascular dialysis catheter, initial Breakdown (mechanical) of surgically created arteriovenous fistula, initial Breakdown (mechanical) of surgically created arteriovenous shunt, initial Breakdown (mechanical) of artificial heart, initial Breakdown (mechanical) of balloon (counterpulsation) device, initial Breakdown (mechanical) of infusion catheter, initial Breakdown (mechanical) of umbrella device, initial Breakdown (mechanical) of other cardiac and vascular devices and implants, initial Displacement of surgically created arteriovenous fistula, initial Displacement of surgically created arteriovenous shunt, initial Displacement of artificial heart, initial Displacement of balloon (counterpulsation) device, initial Displacement of infusion catheter, initial Displacement of umbrella device, initial Displacement of other cardiac and vascular devices and implants, initial Leakage of surgically created arteriovenous fistula, initial Leakage of surgically created arteriovenous shunt, initial Leakage of balloon (counterpulsation) device, initial Leakage of infusion catheter, initial Leakage of umbrella device, initial Leakage of other cardiac and vascular devices and implants, initial Other mechanical complication of surgically created arteriovenous fistula, initial Other mechanical complication of surgically created arteriovenous shunt, initial Other mechanical complication of balloon (counterpulsation) device, initial Other mechanical complication of infusion catheter, initial 26
27 Chapter 19: Injury, poisoning, and certain other consequences of external causes (S00-T88) T82.595A T82.598A T82.6XXA T82.7XXA T82.817A T82.818A T82.827A T82.837A T82.847A T82.857A T82.867A T82.897A T82.9XXA T84.51XA T84.52XA T84.53XA T84.54XA T84.59XA T85.79XA Other mechanical complication of umbrella device, initial Other mechanical complication of other cardiac and vascular devices and implants, initial Infection and inflammatory reaction due to cardiac valve prosthesis, initial Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial Embolism of cardiac prosthetic devices, implants and grafts, initial Embolism of vascular prosthetic devices, implants and grafts, initial Fibrosis of cardiac prosthetic devices, implants and grafts, initial Hemorrhage of cardiac prosthetic devices, implants and grafts, initial Pain from cardiac prosthetic devices, implants and grafts, initial Stenosis of cardiac prosthetic devices, implants and grafts, initial Thrombosis of cardiac prosthetic devices, implants and grafts, initial Other specified complication of cardiac prosthetic devices, implants and grafts, initial Unspecified complication of cardiac and vascular prosthetic device, implant and graft, initial Infection and inflammatory reaction due to internal right hip prosthesis, initial Infection and inflammatory reaction due to internal left hip prosthesis, initial Infection and inflammatory reaction due to internal right knee prosthesis, initial Infection and inflammatory reaction due to internal left knee prosthesis, initial Infection and inflammatory reaction due to other internal joint prosthesis, initial Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial T86.23 Heart transplant rejection - Heart transplant infection T Cardiac allograft vasculopathy T Other complications of heart transplant T T86.33 Heart-lung transplant rejection - Heart-lung transplant infection T86.39 Other complications of heart-lung transplant T88.0XXA T88.59XA Infection following immunization, initial Other complications of anesthesia, initial Factors influencing health status and contact with health services (Z00-Z99) Z01.30 Encounter for examination of blood pressure without abnormal findings Z01.31 Encounter for examination of blood pressure with abnormal findings Z Encounter for preprocedural cardiovascular examination Z Encounter for other preprocedural examination Z08 Z09 Encounter for follow-up exam after treatment for malignant neoplasm Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm Z48.21 Encounter for aftercare following heart transplant Z48.24 Encounter for aftercare following lung transplant Z Encounter for aftercare following heart-lung transplant Z Encounter for aftercare following multiple organ transplant 27
28 Factors influencing health status and contact with health services (Z00-Z99) Z Encounter for aftercare following bone marrow transplant Z Encounter for aftercare following other organ transplant Z51.11 Encounter for antineoplastic chemotherapy Z52.4 Kidney donor Z52.89 Donor of other specified organs or tissues Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) Z79.3 Long term (current) use of hormonal contraceptives Z79.51 Long term (current) use of inhaled steroids Z79.52 Long term (current) use of systemic steroids Z Long term (current) use of opiate analgesic Z Other long term (current) drug therapy Z Personal history of pulmonary embolism Z87.74 Personal history of (corrected) congenital malformations of heart and circulatory system Z94.1 Heart transplant status Z94.2 Lung transplant status Z95.2 Presence of prosthetic heart valve Z95.3 Presence of xenogenic heart valve Z95.4 Presence of other heart-valve replacement Z Presence of heart assist device Z Presence of fully implantable artificial heart Z87.74 Personal history of (corrected) congenital malformations of heart and circulatory system Z95.1 Presence of aortocoronary bypass graft Z Presence of automatic (implantable) cardiac defibrillator Z98.89 Other specified postprocedural states 28
Adult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
Local Coverage Article: NCD Coding Article for Positron Emission Tomography (PET) Scans Used for Non- Oncologic Conditions (A53134)
Local Coverage Article: NCD Coding Article for Positron Emission Tomography (PET) Scans Used for Non- Oncologic Conditions (A53134) Contractor Information Contractor Name Novitas Solutions, Inc. Article
ACCP Inpatient/Facility List
799.02 Hypoxemia R09.02 Hypoxemia 486 Pneumonia, organism unspecified J18.9 Pneumonia, unspecified organism 518.82 Other pulmonary insufficiency, not elsewhere classified J18.8 Other pneumonia, unspecified
Documentation Strategies in an ICD-10 World
Documentation Strategies in an ICD-10 World Providence Holy Cross Medical Center; Mission Hills, CA September 2, 2015 Andrew H. Dombro, MD Internist/Hospitalist; Denver, CO Regional Medical Director JA
ICD-10 Provider Preparation
ICD-10 Provider Preparation After browsing this slide deck, the viewer will become more familiar with the following information: What are the origins of ICD-10? Why transition to ICD-10? Why ICD-10 matters.
NCD for Lipids Testing
Applicable CPT Code(s): NCD for Lipids Testing 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood;
How To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
Cardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians May 19, 2015 Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent
ICD 10 ICD 9. 14, 000 codes No laterality Limited severity parameters No placeholders 3-5 digits
ICD 10 Conversion 1 Why Change? ICD 9 14, 000 codes No laterality Limited severity parameters No placeholders 3-5 digits 1 2 3 4 5 ICD 10 69,000+ codes Indicates Rt or Lt Extensive severity parameters
LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES
Test Code Test Name CPT CHOL Cholesterol, Serum 82465 HDL HDL, (High Density Lipoprotein) 83718 TRIG Triglycerides, Serum 84478 FTRIG Triglycerides (Fluid) 84478 LIPID Lipid Panel 80061 LDL LDL (Low Density
Using the ICD-10-CM. The Alphabetic Index helps you determine which section to refer to in the Tabular List. It does not always provide the full code.
Using the ICD-10-CM Selecting the Correct Code To determine the correct International Classification of Diseases, 10 Edition, Clinical Modification (ICD-10-CM) code, follow these two steps: Step 1: Look
Potential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
Practical class 3 THE HEART
Practical class 3 THE HEART OBJECTIVES By the time you have completed this assignment and any necessary further reading or study you should be able to:- 1. Describe the fibrous pericardium and serous pericardium,
Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview
Hospital-based SNF Coding Tip Sheet: Top 25 codes and Chapter Overview Chapter 5 - Mental, Behavioral and Neurodevelopmental Disorders (F00-F99) Classification improvements (different categories) expansions:
Exchange solutes and water with cells of the body
Chapter 8 Heart and Blood Vessels Three Types of Blood Vessels Transport Blood Arteries Carry blood away from the heart Transport blood under high pressure Capillaries Exchange solutes and water with cells
Preparing for ICD-10 for Physicians
Preparing for ICD-10 for Physicians May 2011 Notices These coding suggestions and coverage guidelines do not replace seeking coding advice from the payer and/or your coding staff. The ultimate responsibility
ICD-10: Navigating the Change. Presented by: Shelley Garrett, CPC, CMC, CMOM, CMIS
ICD-10: Navigating the Change Presented by: Shelley Garrett, CPC, CMC, CMOM, CMIS A journey of a thousand miles begins with a single step -Confucius 5010 Conversion January 1, 2012 5010 Conversion Version
Common types of congenital heart defects
Common types of congenital heart defects Congenital heart defects are abnormalities that develop before birth. They can occur in the heart's chambers, valves or blood vessels. A baby may be born with only
Automatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
ICD-10. Clinical Concepts for Cardiology
ICD-10 Clinical Concepts for Cardiology ICD-10 Clinical Concepts Series Common Codes Clinical Documentation Tips Clinical Scenarios ICD-10 Clinical Concepts for Cardiology is a feature of Road to 10, a
Home Health Care ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Home Health Care and Top 20 codes
Home Health Care ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Home Health Care and Top 20 codes Chapter 4: Endocrine, Nutritional and Metabolic Diseases (E00-E99) ICD-10-CM diabetes mellitus
Speaking ICD-10-CM. The New Coding Language. COPD documented with a more specific respiratory condition falls under one code category: J44.0-J44.
Speaking : Chronic Obstructive Pulmonary Disease (COPD) COPD documented with a more specific respiratory condition falls under multiple code categories: 491.20-491.22 Obstructive chronic bronchitis 493.20-493.22
CMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA
SYSTEMATIC PATHOLOGY I IIIYear Scientific Field DISCIPLINE TUTOR Systematic Pathology I MED/21 MED/10 Thoracic Surgery Respiratory Diseases Tommaso Claudio Mineo Paola Rogliani MED/10 Respiratory Diseases
Local Coverage Determination (LCD): Cardiology non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET (L36209)
Local Coverage Determination (LCD): Cardiology non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET (L36209) Contractor Information Contractor Name First Coast
190.16 - Partial Thromboplastin Time (PTT)
190.16 - Partial Thromboplastin Time (PTT) Other Names/Abbreviations PTT Basic plasma coagulation function is readily assessed with a few simple laboratory tests: The Partial Thromboplastin Time (PTT),
Cardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
CMS CLINICAL ELIGIBILITY ATTESTATION
CMS CLINICAL ELIGIBILITY ATTESTATION Patient Name: DOB: Medicaid and/or KidCare ID: Parent/Legal Guardian Name: Phone number: Initial all that Apply: Initials ICD 10 Descriptor Certain infectious and parasitic
Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99
Natural death Description Code Recommendation Description Code All natural death 001-799 IPH All natural death A00-R99 Infectious and parasitic diseases 001-139 CDC, EUROSTAT, CBS & VG Infectious and parasitic
Heart and Vascular System Practice Questions
Heart and Vascular System Practice Questions Student: 1. The pulmonary veins are unusual as veins because they are transporting. A. oxygenated blood B. de-oxygenated blood C. high fat blood D. nutrient-rich
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
ICD-9-CM coding for patients with Spinal Cord Injury*
ICD-9-CM coding for patients with Spinal Cord Injury* indicates intervening codes have been left out of this list. OTHER DISORDERS OF THE CENTRAL NERVOUS SYSTEM (340-349) 344 Other paralytic syndromes
Local Coverage Determination (LCD) for Echocardiography, Transthoracic and Transesophageal (L28254)
Centers for Medicare & Medicaid Services Print Message: If you are experiencing issues printing this page, then please click Return to Previous Page and select the 'Need a PDF?' button. You can now print
ICD-10-CM KEVIN SOLINSKY, CPC, CPC-I, CEDC, CEMC PRESIDENT HEALTHCARE CODING CONSULTANTS, LLC 480-200-4590
ICD-10-CM KEVIN SOLINSKY, CPC, CPC-I, CEDC, CEMC PRESIDENT HEALTHCARE CODING CONSULTANTS, LLC 480-200-4590 ICD-10 FINAL RULE Implementation date October 1, 2014. ICD-9-CM codes will not be accepted by
Universal Fetal Cardiac Ultrasound At the Heart of Newborn Well-being
Universal Fetal Cardiac Ultrasound At the Heart of Newborn Well-being Optimizes detection of congenital heart disease (chd) in the general low risk obstetrical population Daniel J. Cohen, M.D. [email protected]
PHC4 35 Diseases, Procedures, and Medical Conditions for which Laboratory Data is Required Effective 10/1/2015
PHC4 35 Diseases, Procedures, and Medical Conditions for which Laboratory Data is Required Effective 10/1/2015 Laboratory data is to be submitted for discharges in the following conditions: 1. Heart Attack
General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung
ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle
Chest Pain. Acute Myocardial Infarction: Differential Diagnosis and Patient Management. Common complaint in ED. Wide range of etiologies
Acute Myocardial Infarction: Differential Diagnosis and Patient Management Presented By: Barbara Furry, RN-BC, MS, CCRN, FAHA Director The Center of Excellence in Education Director of HERO Chest Pain
Major Diagnosis Coding ICD-9-CM and ICD-10-CM. Overview
Major Diagnosis Coding ICD-9-CM and ICD-10-CM Jeanne Yoder, RHIA, CCS-P, CPC, CPC-I February 2009 AAPC All Rights Reserved 1 Overview ICD-9-CM and ICD-10-CM Heart Diseases Neoplasms Cerebrovascular Diseases
MEDICAL POLICY No. 91104-R7 DETOXIFICATION I. POLICY/CRITERIA
DETOXIFICATION MEDICAL POLICY Effective Date: January 7, 2013 Review Dates: 1/93, 2/97, 4/99, 2/01, 12/01, 2/02, 2/03, 1/04, 1/05, 12/05, 12/06, 12/07, 12/08, 12/09, 12/10, 12/11, 12/12, 12/13, 11/14 Date
Workshop B: Essentials of Neonatal Cardiology and CHD Anthony C. Chang, MD, MBA, MPH CARDIAC INTENSIVE CARE
SHUNT LESIONS NEONATAL : CONGENITAL CARDIAC MALFORMATIONS AND CARDIAC SURGERY ANTHONY C. CHANG, MD, MBA, MPH CHILDREN S HOSPITAL OF ORANGE COUNTY ATRIAL SEPTAL DEFECT LEFT TO RIGHT SHUNT INCREASED PULMONARY
APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION
APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION ICD-9-CM codes for cerebrovascular diseases is not user friendly. This presentation is designed to assist
F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY
créée sous le Patronage de l'union Européenne Detailed plan of the program of six courses 1. RESPIRATORY 1. ESPIRATORY AND THORAX 1.1 Physics and principles of measurement 1.1.1 Physical laws 1.1.2 Vaporizers
SECTION I - INSTRUCTIONS FOR CLASSIFYING THE UNDERLYING CAUSE OF DEATH, 2013 A. INTRODUCTION
SECTION I - INSTRUCTIONS FOR CLASSIFYING THE UNDERLYING CAUSE OF DEATH, 2013 A. INTRODUCTION This manual provides instructions to mortality medical coders and nosologists for coding the underlying cause
ICD-10 Codes Utilized by Audiologists
ICD-10 Codes Utilized by Audiologists Introduction Beginning with the first claim filed to all payers on or after October 1, 2015, the ICD-10 codes must be utilized in box 21 A-L on the CMS 1500 claim
Certified Registered Nurse Anesthetist ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for CRNA s and Top 25 Codes
Certified Registered Nurse Anesthetist ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for CRNA s and Top 25 Codes Chapter 2 Neoplasms (C00-D49) Classification improvements Code expansions Significant
Right-sided infective endocarditis:tunisian experience
Right-sided infective endocarditis:tunisian experience L. Ammari, A. Ghoubontini, A. Berriche, R. Abdelmalek, S.Aissa, F.Kanoun, B.Kilani, H.Tiouiri Benaissa, T.Ben chaabane Department of Infectious diseases,
Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School
Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School This guide is for middle and high school students participating in AIMS Anatomy of the Human Heart and
CHARGES FOR DRUG-RELATED INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS IN KENTUCKY, 2009-2013
CHARGES FOR DRUG-RELATED INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS IN KENTUCKY, 2009-2013 Prepared for the Kentucky Injury Prevention & Research Center by: Huong Luu, MD, MPH W. Jay Christian,
Questions FOETAL CIRCULATION ANAESTHESIA TUTORIAL OF THE WEEK 91 18 TH MAY 2008
FOETAL CIRCULATION ANAESTHESIA TUTORIAL OF THE WEEK 91 18 TH MAY 2008 Dr. S. Mathieu, Specialist Registrar in Anaesthesia Dr. D. J. Dalgleish, Consultant Anaesthetist Royal Bournemouth and Christchurch
Preoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
Diabetes Mellitus and the Circulatory System
Diabetes Mellitus and the Circulatory System Tricia A. Twombly BSN RN HCS-D HCS-O COS-C CHCE AHIMA Approved ICD-10 CM Trainer AHIMA Ambassador Senior Director DecisionHealth Chief Executive Officer Board
Definitions. Child LifeAdvance. Critical Illness Insurance Plan
Definitions Child LifeAdvance Critical Illness Insurance Plan Child LifeAdvance This is specimen wording only and is not binding. In the event of any inconsistency between the information contained in
LIMITED BENEFIT HEALTH COVERAGE FOR SPECIFIED CRITICAL ILLNESS. OUTLINE OF COVERAGE (Applicable to Policy Form CI-1.0-NC)
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P.O. Box 1365, Columbia, South Carolina 29202 1.800.325.4368 www.coloniallife.com A Stock Company LIMITED BENEFIT HEALTH COVERAGE
David J. Freedman, DPM, FASPS, CPC, CPMA,CSFAC
David J. Freedman, DPM, FASPS, CPC, CPMA,CSFAC Certified Professional coder Certified Professional Medical Auditor Certified Surgical Foot & Ankle Coder www.icdtenhelp.com APMA Coding Committee, member
Day Rehab ICD-10 documentation
Day Rehab documentation Seven key impacts to documentation 1. Disease or disorder site 2. Acuity and/or encounter status of treatment 3. Etiology, causative agent, or disease type and injury/ poisoning
SAMPLE. Anesthesia Services. An essential coding, billing, and reimbursement resource for anesthesiology and pain management ICD-10
Coding and Payment Guide www.optumcoding.com Anesthesia Services An essential coding, billing, and reimbursement resource for anesthesiology and pain management 2017 a ICD10 A full suite of resources including
Ischemia and Infarction
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to
Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium
Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation
ICD-10 Transition & Implementation Information
ICD-10 Transition & Implementation Information I ICD-10 Implementation Compliance Date: October 1, 2015 ICD-10-CM diagnoses codes will be used by all providers in every health care setting. ICD-10-PCS
Breaking the Code: ICD-9-CM Coding in Details
Breaking the Code: ICD-9-CM Coding in Details ICD-9-CM diagnosis codes are 3- to 5-digit codes used to describe the clinical reason for a patient s treatment. They do not describe the service performed,
Present on Admission Reporting Guidelines
Introduction Present on Admission Reporting Guidelines These guidelines are to be used as a supplement to the ICD-9-CM Official Guidelines for Coding and Reporting to facilitate the assignment of the Present
Kathryn DeVault, RHIA, CCS, CCS-P Director, HIM Solutions, AHIMA
ICD-10-CM: Let s Code, Part II Kathryn DeVault, RHIA, CCS, CCS-P Director, HIM Solutions, AHIMA Agenda Coding questions answered Review of ICD-10-CM coding scenarios ICD-10-CM Coding Questions Coding Questions...
HCIM ICD-10 Training Online Course Catalog August 2015
HCIM ICD-10 Training Online Course Catalog August 2015 Course/Content Duration Quiz Duration CME Credits Assessments: Assessment: Provider - Baseline - E/M Emergency Department 45 5/1/2015 Assessment:
Guidelines Most Significantly Affected Under ICD-10-CM. May 29, 2013
Guidelines Most Significantly Affected Under ICD-10-CM May 29, 2013 Guidelines Most Significantly Affected Under ICD-10-CM A look at the new system and how it compares to ICD-9-CM Presented by Therese
Mortality statistics and road traffic accidents in the UK
Mortality statistics and road traffic accidents in the UK An RAC Foundation Briefing Note for the UN Decade of Action for Road Safety In 2009 2,605 people died in road traffic accidents in the UK. While
Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.
Chest Pain in Young Athletes Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego [email protected] 858-966-5855 None Disclosures Chest Pain: the good news and the bad news:
The Newborn With a Congenital Disorder. Chapter 14. Copyright 2008 Wolters Kluwer Health Lippincott Williams & Wilkins
The Newborn With a Congenital Disorder Chapter 14 Congenital Anomalies or Malformations May be caused by genetic or environmental factors Approximately 2% to 3% of all infants born have a major malformation
Advanced Specialist Training (AST) Programme in Cardiology
I. Definition Cardiology is a medical subspecialty concerned with the prevention, diagnosis, management, and rehabilitation of patients with diseases of the cardiovascular system. A cardiologist is a specialist
Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it.
Heart Failure EXERCISES Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it. ) 1. Heart rate increase is a kind of economic compensation, which should
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES
INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES NOTICE: This is an introductory guide for a user to understand basic ECG tracings and parameters. The guide will allow user to identify some of the
ICD-10 in the Provider Newsletter
ICD-10 in the Provider Newsletter ICD-10 CM Code Structure, July 2013 ICD-10 Implementation, April 2013 ICD-10 Manual, January 2013 ICD-10 Back on Track, October 2012 ICD-10 Training, July 2012 ICD-10
ADVANCED P.G. DIPLOMA IN ECHO CARDIOGRAPHY AND SONOGRAPHY
ADVANCED P.G. DIPLOMA IN ECHO CARDIOGRAPHY AND SONOGRAPHY INSTRUCTION & EXAMINATION W.E.F 2014-2015 SEMESTER - I S.No Paper Subject Scheme of instruction hrs/ week L/T D/P Scheme of examination Duration
Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.
Management of Acute Left Ventricular Failure Acute left ventricular failure presents as pulmonary oedema due to increased pressure in the pulmonary capillaries. It is important to realise though that left
A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs
A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory
Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock
Chapter 16 Shock Learning Objectives Explain difference between compensated and uncompensated shock Differentiate among 5 causes and types of shock: Hypovolemic Cardiogenic Neurogenic Septic Anaphylactic
Cardiac Computed Tomographic Angiography (CCTA)
Cardiac Computed Tomographic Angiography (CCTA) DESCRIPTION Contrast-enhanced computed tomography angiography (CTA) is a noninvasive imaging test that requires the use of intravenously administered contrast
Highlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008
Highlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008 Please refer to the complete ICD-9-CM Official Guidelines for Coding and Reporting posted on this
Chapter 2 Cardiac Interpretation of Pediatric Chest X-Ray
Chapter 2 Cardiac Interpretation of Pediatric Chest X-Ray Ra-id Abdulla and Douglas M. Luxenberg Key Facts The cardiac silhouette occupies 50 55% of the chest width on an anterior posterior chest X-ray
Pathology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Pathology and Top 25 codes
Pathology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Pathology and Top 25 codes Chapter 2 Neoplasms (C00-D49) Classification improvements Code expansions Significant expansions or revisions
ICD-10 CM Training. Family Practice
ICD-10 CM Training Family Practice ICD-10-CM Compliance Dates ICD-10-CM will be valid for dates of service on or after October 1, 2015 Outpatient dates of service of October 1, 2015 and beyond. Inpatient
HEdis Code Quick Reference Guide Disease Management Services
HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)
THE HEART Dr. Ali Ebneshahidi
THE HEART Dr. Ali Ebneshahidi Functions is of the heart & blood vessels 1. The heart is an essential pumping organ in the cardiovascular system where the right heart pumps deoxygenated blood (returned
Term Critical Illness Insurance
Term Critical Illness Insurance PRODUCT GUIDE 5368-01A-JUL14 ASSUMPTION LIFE This document is a summary of the various features of Assumption Life's products. It is neither a contract nor an insurance
INTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
Cancer and Heart/Stroke coverage
Cancer and Heart/Stroke coverage Assurant Supplemental Coverage» Pays cash right to you You never expect a life-threatening illness like cancer, heart attack or stroke. But if the unexpected happens to
Chapter 20: The Cardiovascular System: The Heart
Chapter 20: The Cardiovascular System: The Heart Chapter Objectives ANATOMY OF THE HEART 1. Describe the location and orientation of the heart within the thorax and mediastinal cavity. 2. Describe the
Diagnosis Codes for Pregnancy and Complications of Pregnancy
This list is for informational purposes only and is not a binding or definitive list of covered conditions. It is not a guarantee of coverage; coverage depends on the available benefits and eligibility
Medical Surgical Nursing (Elsevier)
1 of 6 I. The Musculoskeletal System Medical Surgical Nursing (Elsevier) 1. Med/Surg: Musculoskeletal System: The Comprehensive Health History 2. Med/Surg: Musculoskeletal System: A Nursing Approach to
020 // Congenital Heart Disease
020 // Congenital Heart Disease CONTENTS 188 Basics 188 Atrial Septal Defect (ASD) 191 Patent Foramen Ovale (PFO) 192 Ventricular Septal Defects (VSD) 194 Patent Ductus Arteriosus (PDA) 195 Coronary Fistulas
DIAGNOSIS CODING TIPS INDEX
4665 Business Center Drive Fairfield, California 94534 DIAGNOSIS CODING TIPS INDEX Coding Tip Page 1. Diabetes 3 2. Asthma 3 3. Hypertention 3 4. Highest Specificity 5 th Digit Pain or Arthritis 3 5. Neoplasm
Case III. Disscussion. the UHP ultrasound protocol. Novel Ultrasound Approach to the Empiric Evaluation of the Undifferentiated Hypotensive Patient
The UHP Ultrasound Protocol: A Novel Ultrasound Approach to the Empiric Evaluation of the Undifferentiated Hypotensive Patient JOHN S. ROSE, MD,* AARON E. BAIR, MD,* DIKU MANDAVIA, MD, AND DONNA J. KINSER,
